Login to Your Account



Financings Roundup

Oncomed Sets Price Range; Seeks $60M in Proposed IPO

By Jennifer Boggs
Managing Editor

Thursday, July 11, 2013
More than a year after filing an S-1 for an initial public offering (IPO), Oncomed Pharmaceuticals Inc. set proposed terms, seeking to sell 4 million shares priced between $14 and $16.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription